Xue-min Yao
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer.
Journal: Drug development and industrial pharmacy
Published: December 09, 2020
Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment.
Journal: Journal of drug targeting
Published: June 03, 2020
GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial-mesenchymal transition.
Journal: Drug development and industrial pharmacy
Published: May 05, 2020
Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis.
Journal: Journal of liposome research
Published: April 01, 2020
Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition.
Journal: Journal of liposome research
Published: March 24, 2020
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Journal: Drug development and industrial pharmacy
Published: March 13, 2020
RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
Journal: Cancer science
Published: September 07, 2019
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
Journal: Journal of drug targeting
Published: August 30, 2019
Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: May 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026